April 22, 2014

PRESS RELEASE: Joint Statement on TPP: U.S. Chamber of Commerce, U.S-Japan Business Council, Keidanren, and Japan-U.S. Business Council

  OUR LATEST ON TWITTER

Global Innovation Policy Center @globalIPcenter 10h

“Waiving drug companies' intellectual property rights risks setting a bad precedent for future investment in new drugs. And that risk may not be worth it without additional steps to meaningfully increase the availability of shots across the world.” https://t.co/UE6nqe8Cyb

Reply Retweet Favorite


Subscribe for updates from GIPC